Pneumococcal disease is often a complication of the flu. Researchers are studying an investigational vaccine which may provide protection against pneumococcal disease in healthy adults age 50 and older. This study will test the effectiveness and safety of an approved flu vaccine used in unison with an investigational vaccination which may help fight infections that can cause pneumococcal disease.
You may qualify for this study if you are 50 years of age or older and:
- Are in good health
- Have no history of invasive pneumococcal disease
- Have no hypersensitivity to any component of influenza vaccines, such as egg protein
- Have not received any influenza vaccine during the 2018-2019 flu season
The study doctor will review additional criteria with you to determine whether you can participate in the study.
For more information, please contact:
Please fill out your information below and a Heartland Research specialist will contact you with more information for this study.
The information you provide is entered in our secure, password protected database. The provided information will only be used to contact you to tell you more about the study. You have the choice to have your information saved or removed from our records. If you elect to have contact information saved within our database, it will remain indefinitely. To be removed please call a Heartland Research specialist at 316-689-6626 or email email@example.com.